Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NKRF | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | RP11-729L2.2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | EEF1A1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
mRNA | APOL4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ASUN | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | MRPL55 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | TMEM217 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ALAS2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | PPP1R15B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | COX5B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |